Substance / Medication

Bismuth subsalicylate

Overview

Active Ingredient
bismuth subsalicylate
RxNorm CUI
19478

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy of bismuth subsalicylate on the prevention of travellers' diarrhoea, 2018-2023.
Angelo Kristina M, Salah Zainab, Rogova Marina et al. · J Travel Med · 2025
PMID: 40439228RCTFull text (PMC)
Saccharomyces boulardii and bismuth subsalicylate as low-cost interventions to reduce the duration and severity of cholera.
Sheele Johnathan, Cartowski Jessica, Dart Angela et al. · Pathog Glob Health · 2015
PMID: 26260354RCTFull text (PMC)
Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
Yakoob Javed, Abbas Zaigham, Usman Muhammad Waqas et al. · Microb Drug Resist · 2014
PMID: 23844851Observational
Successful Suppression of Drug-ResistantInfection With Bismuth Subsalicylate.
Geng Calvin, Prokesch Bonnie C, Vemulapalli Roopa · Open Forum Infect Dis · 2022
PMID: 35755772Case ReportFull text (PMC)
Bismuth Subsalicylate Poisoning.
Meaden Christopher W, Calello Diane P · N Engl J Med · 2022
PMID: 36449423Case Report
Salicylate toxicity from chronic bismuth subsalicylate use.
Halani Sheliza, Wu Peter E · BMJ Case Rep · 2020
PMID: 33257373Case ReportFull text (PMC)
Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate.
Wolf Douglas C, Wolf Christine H, Rubin David T · Am J Gastroenterol · 2020
PMID: 32516203Case ReportFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Bismuth subsalicylate (substance)
SNOMED CT
82075003
UMLS CUI
C0053792
RxNorm CUI
19478

Clinical Data

This intervention maps to 4 entities in the Healos knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.